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Since  the  adaptation  of semisolid culture  methodology to  the  cloning of 
mitogen-stimulated lymphocytes (1), progress has been rapid in defining culture 
variables which affect colony formation and characterization of the cells that 
proliferate.  It  is now apparent that  lymphocyte colony formation is  strictly 
mitogen dependent and that most B cells which clone bear IgM and Ia receptors; 
are widely distributed anatomically; are dependent on macrophages in addition 
to 2-mercaptoethanol (2ME)~; and have a sensitivity to divalent anti-immuno- 
globulin  (Ig)  or anti-Ia  antibodies,  which is  characteristic  of mature B-cell 
populations (2-5). Our understanding of the cells that form colonies is extended 
by the present studies of two well-characterized, genetically controlled, murine 
immunodeficiencies. Extensive studies with CBA/N mice reveal their X chro- 
mosome-linked inability to mount normal immune responses to thymus-inde- 
pendent antigens and poor in  vitro responsiveness to  B-cell  mitogens (6-9). 
Associated with this defect is a reduced number of splenic B cells, low serum 
IgM levels, an abnormally high ratio  of B-cell surface IgM relative to puta- 
tive IgD, and an immature pattern of cell surface Ig-density distribution (10-13). 
Evidence  is  presented  here  that  homozygous CBA/N  mice  lack  functional 
colony-forming B  cells  entirely  and confirms that  this  defect is  intrinsic to 
B  cells.  C3H/HeJ  strain  mice  have  been  well  studied for  their  genetically 
controlled hyporesponsiveness to certain forms of lipopolysaccharide (LPS) (14- 
18). They were found to have extremely low but detectable numbers of colony- 
forming B cells. These results suggest a  selectivity of the cloning assay for a 
functional subpopulation of B cells and further define these animal models of 
immune-deficiency disease. 
Materials and Methods 
Animals.  CBA/N mice were raised under specific pathogen-free conditions at Sloan-Kettering 
Institute from a  breeding stock  obtained from the N.I.H., Bethesda,  Md.  or were obtained as 
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Abbreviations  used  in this paper:  AM, agar-derived mitogens; B1, B lymphocytes which are 
developmentally  thymus-independent  and functionally  independent  of thymus-derived  cells; B2, B 
cells  which are functionally dependent on cooperative  interactions with thymus-derived cells; 
CFU-c; granulocyte-macrophage progenitors; CFU-s; multipotential stem cells; Con A, concana- 
valin A; CR, receptors for the third component of complement; DS, dextran sulfate; FCS, fetal 
bovine serum; I=IUdR, l~I-iododeoxyuridine;  LPS, lipopolysaccharide;  2 ME, 2-mercaptoethanol; 
m~b, adherent macrophages;  PBS, phosphate-buffered saline. 
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adults from Altick Associates, Hudson, Wis. CBA/Cum (obtained from Cumberland View Farms, 
Clinton, Tenn.) or CBA/H-%Te mice (maintained at Sloan-Kettering from a  stock derived from 
The Jackson Laboratories, Bar Harbor, Maine) of either sex were used as controls for experiments 
involving CBA/N mice. Macrophages for some experiments were obtained from (C57BL/6 × DBA! 
2)F~  mice  (Cumberland View  Farms).  Initial experiments with C3H  mice  involved C3H/StCR 
(Charles River Breeding Laboratories,  Wilmington, Mass.) and wild-type C3H/HeJ mice from a 
colony derived from The Jackson Laboratories and on which the W x mutation is maintained. Later 
experiments were done comparing C3H/HeJ  and C3HeB/FeJ mice obtained as adults from The 
Jackson Laboratories. 
Cell Cultures.  Semisolid and liquid cell cultures as well as granulocyte-macrophage progeni- 
tor  (CFU-c)  cell  assays  were  performed  essentially as  described  before  (2)  with the following 
modifications. Conventional liquid mitegen cultures and clonal assays were incubated in 7% CO2 
in fully humidified air. A single batch of fetal bovine serum (FCS) (lot no. 1027; Flow Laboratories, 
Inc.,  Rockville, Md.) was used throughout. This particular serum supports slightly fewer B-cell 
colonies in agar mitogen-stimulated cultures than some other batches which we tested, but was 
selected because it caused an acceptably low background stimulation in liquid cultures.  Agar- 
supported cultures were potentiated by the addition of LPS (10 ~g/ml culture),  sheep red blood 
cells (SRBC)  (0.1  ml of a  5% solution of washed SRBC obtained from Flow Laboratories, Inc.), 
macrophage feeder layers, or combinations of these. Feeder layers were prepared by allowing 10  ~ 
thioglycolate-activated peritoneal  macrophages  to  adhere  to  Lux  Contur  culture  dishes  (Lux 
Scientific Corp., Thousand Oaks, Calif.) which were subsequently washed and overlaid with a 1 ml 
layer of 0.5% agar containing complete medium and 1.4 ×  10 -7 M indomethacin. A full discussion 
of this procedure and its effects will be presented elsewhere3 Briefly, this insures an adequate 
supply  of diffusible  macrophage-derived  factors,  prevents  prostaglandin-mediated  inhibition, 
which results from an overabundance of macrophages, and results in colony formation which is a 
linear function of the number of B cells cultured.  Mitogens used for stimulating liquid cultures 
were  LPS  from Salmonella typhosa  W0901  (Difco Laboratories,  Detroit,  Mich.},  5  ttg/culture; 
agar-derived mitogens (AM) prepared as described (2), 25 fig/culture; dextran sulfate (DS) (mol 
wt 500,000;  Pharmacia Fine Chemicals, Inc., Piscataway, N. J.), 20 ttg/culture; and concanavalin 
A  (Con A) (Pharmacia Fine Chemicals, Inc.)  , 5  t~g/culture.  B-cell differentiation was assessed 
after 3-5 days of incubation with LPS using the same culture conditions as for stimulation or in 
low-cell density liquid cultures prepared according to the method of Kearney and Lawton (19). 
Cells were harvested from replicate cultures,  pooled,  evaluated by phase-contrast microscopy, 
and  slides prepared  with  a  cytocentrifuge.  These  were  fixed  and  stained for  the  presence  of 
cytoplasmic  immunoglobulin  with  rhodamine-labeled  (Fab')2  fragments  of  anti-t~  antibodies 
described elsewhere (3}. 
Titration of Serum Inhibitor Levels.  Individual samples of blood were collected from the tail, 
allowed to clot at room temperature, and the serum was separated. To 1 ml semisolid cultures of 
105 CBA/Cum lymph node cells was added 0.1 ml of phosphate-buffered saline (PBS) or serum 
dilutions. Colonies were scored 5 days later, and the dilution required to reduce colony numbers by 
half determined. 
Detection of Multipotential  Stem Cells.  The incidence of multipotential stem cells (CFU-s) in 
bone marrow cell suspensions was determined by injecting 5  ×  104 cells into lethally irradiated 
(850 R) CBA/Cum mice and enumerating macroscopic colonies on the surface of the Bouin's fixed 
spleens 8 days later. 
Results 
Inability of CBA/N B  Cells to Form Colonies.  When lymphoid cell suspen- 
sions from the spleen,  lymph nodes,  or peripheral  blood of adult homozygous 
CBA/N mice were cultured in agar, no B-cell colonies were formed. In hundreds 
of such  cultures  initiated  with  up  to  10  e  lymphocytes  per  culture,  only  one 
possible  B-cell  colony  was  observed.  Attempts  were  made  to  induce  colony 
2 Kurland, J. I., P.  W.  Kincade, and M. A. S.  Moore. Regulation of B lymphocyte clonal pro- 
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TABLE  I 
Inability of CBA/N B  Cells to Form Colonies 
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Colonies/culture 
Cells  cultured  Potentiated by:  _+ SD 
CBA/H-TeT6 spleen  PBS  49 -+ 7 
LPS  248  _+  49 
SRBC  386  -+ 40 
LPS  +  SRBC  482  _+  55 
Md>  262  -+ 61 
M~  +  SRBC  >500 
Md~  +  LPS  >500 
CBA/H-T~Te lymph node 
CBA/N spleen 
CBA/N lymph node 
PBS  4  -+ 2 
LPS  76  -+ 20 
SRBC  195  _+  32 
LPS  +  SRBC  287  _+ 55 
M&  135  _+  37 
M&  +  LPS  196  -+  12 
PBS  0 
LPS  0 
SRBC  0 
LPS + SRBC  0 
M~  0 
M&  + SRBC  0 
M~b + LPS  0 
M&  + SRBC  + LPS  0 
PBS  0 
LPS  0 
SRBC  0 
LPS  +  SRBC  0 
M~  0 
Mob  +  SRBC  0 
M&  +  LPS  0 
M~  +  SRBC  +  LPS  0 
All cultures were initiated with 5  ×  104 nucleated cells alone or potentiated by 
the addition  of LPS,  SRBC,  macrophages (M&),  or combinations of these as 
described  in  the  Materials  and  Methods.  B-cell colonies were scored after  5 
days culture. 
formation by addition of LPS, SRBC, or macrophages to the cultures. These 
agents potentiate size and number of colonies and improve the linearity of the 
assay for responding cell populations (references 1, 2, and 4; and J. I. Kurland, 
P. W. Kincade, and M. A. S. Moore, unpublished observations). Representative 
experiments are shown in Table I. CBA/N B cells did not form colonies under 
any circumstances. When high numbers of spleen cells were cultured, some 
spontaneous granulocyte colonies were  observed,  and since the  macrophage 
feeders can elaborate colony-stimulating  activity, granulocyte-macrophage colo- 
nies were frequently observed in cultures potentiated in this way. These were 
easily distinguishable from B-cell colonies which are composed of less refractile, 
smaller appearing cells. If any B cells capable of colony formation are present in 
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TABL~  II 
Colony Formation by Mixtures  of CBA/N and Normal B Cells 
Exp. I 
CBA/N  Lymph node  (106) *  05 
Spleen  ( 105  )  0 
CBA/H-T6T6  Lymph node  (5  ×  104)  60  +_ 6 
(105)  164  +_  14 
CBA/H-T~T~  Spleen  (5  ×  104}  417  __+ 35 
(105)  1,518  _+  150 
CBA/N (5  ×  104) +  CBA/H-T6T6  (5  ×  104) lymph node  74  _+  9 
CBA/N (5  ×  104) +  CBA/H-T6T6  (5  × 
Exp. II 
CBA/H-%T6 lymph node  (5  ×  104) + 
104) spleen  413  +_  41 
PBS  21  _+  1 
LPS  112  +_  12 
M(b  169  _+  14 
104 CBA/N spleen  32  _+  5 
5  x  104 CBA/N spleen  28  -+  11 
105 CBA/N spleen  31  _+  3 
CBA/H-T6T6 lymph node  (105)  +  PBS  80  -+ 8 
LPS  214  _+  32 
M4~  355  _+ 54 
104 CBA/N spleen  162  +_  10 
5  ×  104 CBA/N spleen  136  +  15 
105 CBA/N spleen  151  -+  12 
* Number of cells cultured. 
$ Mean number of colonies in three to four replicate cultures +_ SD. 
Colony Formation  by Mixtures  of CBA/N and Normal B Cells.  To exclude 
active suppressor mechanisms in CBA/N lymphoid cell suspensions, mixtures of 
normal and CBA/N cells were cultured together (Table II). CBA/N cells did not 
interfere with,  and  even occasionally potentiated slightly,  the formation of 
colonies by normal B cells. This slight enhancement  was expected since addition 
of nonlymphoid cells to  unpotentiated B-cell cultures increases cloning effi- 
ciency (1). 
Mitogen  Responses  of CBA/N B  Cells  in  Liquid  Cultures.  It  has  been 
documented that CBA/N B cells are capable of subnormal but detectable prolif- 
erative responses to certain mitogens in liquid cultures (8-10). Since mitogens 
native to agar are important for B-colony formation (2), it was important to test 
the ability of CBA/N mice to respond to these mitogens. Reactivity of CBA/N B 
cells to LPS, as assessed by luI-iododeoxyuridine (I~'~IUdR) uptake after 3 days 
in liquid culture, was variable but often quite vigorous (Table HI). The prolifera- 
tive responses of CBA/N B cells to agar-derived mitogens or dextran sulfate was 
more consistently lower than that of CBA/H or CBA/Cum lymphocytes  but were 
still often measurable. When low responses to mitogens in liquid cultures were 
obtained, they could be restored by the addition of normal cells (Fig. 1). It has 
been reported that mitogen-stimulated lymphocytes  can incorporate radioactive PAUL  W.  KINCADE  253 
TABLE III 
Mitogen Responsiveness of CBA/N Lymphocytes in Liquid Cultures* 
Mitogen  -FCS  +FCS 
CBA/N  spleen  AM  3.5, 5.6, 1.9,  0.9  3.7, 6.6, 4.2,  3.7 
LPS  15.2, 28.1, 14.8, 2.6  8.7, 90.5, 54.3, 33.6 
DS  0.7, 1.0,  1.1,  0.6  2.0, 1.6,  2.1, 1.2 
Con A  0.3, 1.7,  1.3,  0.6  42.6, 206.9, 198.4, 90.5 
CBA/N lymph node  AM  1.4,  1.0,  1.1  3.7,  1.2 
LPS  1.2,  1.0,  1.5  55.7, 7.9 
DS  1.0,  1.2  0.7, 0.5 
Con A  0.6,  1.0,  1.1  318.8,  36.5 
CBA]Cum  or  CBA/H-TeT6  AM  7.1,  10.7,  13.6  1.2,  3.2, 2.0 
spleen  LPS  5.7, 6.7, 13.0  1.7,  3.0, 3.1 
DS  2.0,  0.6, 0.5  3.3, 2.7, 3.4 
Con A  0.1,  0.1,  0.3  5.4, 4.9,  17.8 
CBA/Cum  or  CBA/H-TsT~  AM  7.0,  3.1,  9.7  8.6,  11.1,  5.0 
lymph node  LPS  4.1, 2.9,  3.3  5.3,  15.6,  5.3 
DS  2.0,  0.5,  1.1  2.0,  1.1,  1.5 
Con A  0.4, 0.4,  0.7  1.1,  2.3,  13.6 
*Data are means of  triplicate  cultures  expressed as the ratio  of  125IUdR incorporation  in  mitogen- 
containing cultures  to  that  of  the same cells  cultured  in  medium alone.  Each column of  figures  is 
the result  of separate experiments with unpooled cell  suspensions from individual mice in 
cultures  containing 5% fetal  calf  serum or  serum-free medium. 
thymidine into DNA without actually dividing (20). To determine if CBA/N B 
cells lack the ability to proliferate over a 5 day period as is required for colony 
formation and to test the validity of using 125IUdR uptake as an index of cell 
division, in a single experiment hemocytometer cell counts were performed on 3- 
and 5-day liquid cultures  (Table IV).  Isotope incorporation agreed reasonably 
well with actual cell recoveries and the presence of large, presumably respond- 
ing, cells in the cultures.  These findings suggest that the failure of CBA/N B 
cells to form colonies in a  mitogen-stimulated  gel culture  is not due to total 
unresponsiveness to the mitogens that are present. 
Differentiation of CBA/N B cells in Liquid Cultures.  In addition to activat- 
ing  B  cells  to  proliferate,  certain  mitogens  cause  maturation  to  high-rate 
immunoglobulin-secreting plasma cells. Since CBA/N cells display some prolif- 
erative responsiveness to mitogens, their ability to differentiate during 3-5 days 
of liquid culture with LPS was tested.  Using the same  conditions as for the 
previously discussed proliferation assays,  CBA/N B-cell cultures contained al- 
most  as  high  a  percentage  of well-developed  plasma  cells  as  the  controls. 
Differentiation is known to be very dependent on cell density (19, 21), so cultures 
were prepared under low-density conditions which favor expression of all classes 
of immunoglobulin. Normal spleen cells matured well under these conditions 
but  surprisingly  CBA/N  cells  proliferated  poorly  and  very  few  large  IgM- 
containing cells were found. An experiment illustrating these points is shown in 
Table V.  Other experiments utilizing a  scaled  up version of the protocol em- 
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Cullure in Serum Containing Medium 
20  10 
16  8 
x 
¢3 
12  61 
::  t  ~  4 
25  50  75  100 
Culture in Serum-Free  Medium 
25  50  75  100 
% of CBA/H-T6T6 Ceils 
Fzo.  1.  Mitogen response of mixtures of CBA/N and normal lymph node cells in liquid 
culture. A constant number of cells mixed in different ratios were cultured with LPS (open 
triangles),  agar mitogens  (closed squares),  DS  (open circles),  or PBS  (closed circles)  in 
either  5%  fetal  ca',f serum  or  in  serum-free  medium.  Each  point is the  mean  12'~IUdR 
incorporation of triplicate cultures after 3 days. 
TABLE  IV 
Proliferative Ability of CBA/N B Cells in Mitogen-Stimulated  Liquid Cultures Assessed 
by Cell Counting and 1~sIUdR Uptake 
Mi~gen 
Day 3  Day 5 
% Recovery  % Large  ~I (cpm)  % Recovery  % Large  ~2Sl  (cpm) 
CBA/N 
CBA/H-T6T6 
PBS  10  22  88  21  11  119 
AM  9  13  540  24  14  737 
LPS  35  44  9,467  64  40  2,055 
DS  12  9  107  3  1  61 
Con A  88  75  89,752  209  89  8,466 
PBS  42  21  1,796  32  28  707 
AM  41  68  5,982  63  44  1,696 
LPS  104  79  14,659  110  75  3,330 
DS  21  68  6,618  32  72  7,534 
Con A  143  81  59,873  231  86  7,374 
Liquid microcultures were harvested, pooled, and the percentage of the starting number  of viable cells  recovered and the 
percentage of  large  cells  determined by  phase-contrast  microscopy. Identical  cultures  were pulsed with t251UdR,  and  the amount of 
TCA precipitable  radioactivity  determined 4 h later.  All cultures  contained 5% fetal  calf  serum. 
mined normal or defective activation and maturation of CBA/N B cells in liquid 
cultures  (data  not  shown).  Furthermore,  many  of the  IgM-containing  cells 
observed  in  low-density  CBA/N  liquid  cultures  were  found  in  clumps,  and 
aggregation in the cultures could be responsible for the small number of these 
cells which were seen. 
Serum Inhibitor Levels in CBA/N Mice.  Normal mouse serum is known to 
contain  inhibitors  for various in vitro  assays  (22,  23),  and the  B-cell-cloning 
assay is no exception. Addition of undiluted serum from several different strains 
of mice resulted in greater survival of single, small cells, but almost completely 
inhibited  colony formation.  Serum samples  from six different  CBA/Cum  and 
five  different  CBA/N  mice  were  titered  for this  inhibitor  activity.  Using the 
maximum final dilution of serum necessary to inhibit proliferating foci by 50% PAUL  W.  KINCADE 
TABLE  V 
The Effect of Cell Density on CBA/N B-Cell Proliferation and Differentiation 
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Culture  conditions  Cells  LPS 
'25IUdR  uptake 
%  Recovery  %  IgM + cells  (cpm) 
3 days  5 days  3 days  5 days  3 days  5 days 
Conditions  used  throughout  this  CBA/N 
study to assess mitogen stimulation 
(4  ×  10  s cells/culture,  7%  CO~,  5% 
FCS)  CBA/H 
Same as above except  5  x  104 cells/  CBA/N 
culture 
CBA/H 
Conditions  used  by  Kearney  and  CBA/N 
Lawton  (19)  (5  ×  104 cells/culture, 
5% CO.~, 20% FCS) 
CBA/H 
-  59  28  <0,1  0.5  153  707 
5  108  75  25.9  22.2  12,669  5,083 
50  86  107  27.5  35.9  10,345  3,838 
-  53  20  4.5  14.4  413  338 
5  162  108  37.6  38.0  6,038  559 
50  166  114  54.9  50.2  4,934  1,024 
--  5  2  0.1  0.1  20  32 
5  8  3  5.0  2.6  187  49 
50  7  2  17.5  5.3  63  43 
10  3  2.4  6.6  43  22 
5  23  21  54.3  69.2  5,387  1,631 
50  21  17  55,6  65.4  3,800  1,103 
4  2  0.1  <0.1  28  53 
5  5  2  0.9  ND  40  54 
50  9  l  5.8  ND  68  52 
-  6  3  0.4  2.1  39  45 
5  13  69  40.9  63.6  7,896  9,819 
50  33  113  45.3  65.1  8,295  9,458 
Cultures  were initiated  with cell  suspensions  from  individual  mice  in  Falcon  Microtest  II  plates.  The fraction  of the starting 
number of viable cells recovered after 3 or 5 days of culture was determined by phase-contrast microscopy. At least 500 intact cells 
were evaluated in cytocentrifuge  preparations by immunofluorescence  and cells with abundant,  intensely  fluorescent cytoplasm 
were recorded as IgM ÷, 
as an index of inhibitor concentration, sample-to-sample variability was seen 
(range 1/30 to 1/90),  but no difference was attributable to the strain of origin of 
the serum (data not shown). These experiments indicate that CBA/N mice have 
adequate, but not elevated, levels of serum factors which may be important for 
B-cell regulation in vivo. 
Incidence of Other Functional Hemopoietic Cells in CBA/N Mice.  Further 
evidence for restriction of the lesion of CBA/N mice to B celis was obtained by 
determining the frequency of CFU-c and CFU-s in the marrow of CBA/N mice. 
These values were within normal range (79  ~  11 CFU-c and 22 __+ 2 CFU-s/5  × 
104 CBA/N bone marrow cells; 73 _+ 7 CFU-c and 16 _  4 CFU-s/5  x  104 CBA/H- 
T6T~ bone marrow cells). 
B-Cell  Colony  Formation  by  C3H  Mice.  We  had  previously  noted  that 
lymphocytes  from C3H/HeJ  mice were normal  in their ability  to form B-cell 
colonies  (2).  This  was based  on  several  experiments  employing  mice  from a 
colony of C3H/HeJ mice on which we maintain the W x mutation. Heterozygous 
W×/+  or wild-type  +/+  C3H/HeJ mice had as many colony-forming B  cells as 
C3H/St mice. More recently, we obtained other C3H/HeJ mice which were not 
associated  with the  W ~ mutation colonies from The Jackson  Laboratory,  and 
colony formation by their B lymphocytes was defective  (Table VI).  Unlike cell 
suspensions  from CBA/N  mice,  there were a  small number of colony-forming 
cells in the C3H/HeJ spleen and lymph nodes which formed normal size colonies 
and whose size and number were slightly potentiated  by agents  that  had no 
effect on CBA/N B cells. 
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TABLE  VI 
B Lymphocyte Colony Formation by Different Strains of C3H Mice 
Experiment  Experiment  Experiment 
I  II  III 
C3H/HeJ  5 x  104 Spleen cells  +  PBS  4  _+  2*  2  _+  1  2  +_  1 
LPS  11  _+  1  4  _+  2  2  _+  2 
SRBC  6  -+  2 
Macrophages  21  _+  4 
105 Lymph node cells  +  PBS  5_  2  2  _+  2  1 +-  1 
LPS  27  _+  5  17  +_  8  0 
SRBC  12  _+  9 
Macrophages  25  +_  6 
C3HeB/FeJ  5 ×  104 Spleen cells  +  PBS  197  ±  20  237  _+  14  137  +_  43 
LPS  303  _+  17  377  _+  33  174  +_  51 
SRBC  340  +-  17 
Macrophages  286  _+  26 
I05 Lymph node cells  +  PBS  170  _+  10  185  _+  19  155  _+  17 
LPS  341  _+  30  298  -+  15  213  _+  13 
SRBC  338  -  41 
Macrophages  324  _+  32 
C3H/HeJW~/+  5  x  104 Spleen cells*  +  PBS  240  _+  17 
LPS  241  +  18 
102 Lymph node cells  +  PBS  55  _+  13 
LPS  32  +- 9 
* Mean number of colonies in three to four replicate cultures _  SD. 
* Similar results were obtained with cells from homozygous +/+ mice from this colony. 
ported,  C3H/HeJ mice were poor responders to LPS in liquid cultures (Table 
VII). Excellent stimulation was seen, however, when the same cell suspensions 
were incubated with agar mitogens or dextran sulfate. Not surprisingly, our 
colony of C3H/HeJ Wx/+ mice responded to LPS in keeping with their colony- 
forming ability. 
Potentiation  of  B-Cell  Cloning  by  CBA/N  and  C3H/HeJ  Macro- 
phages.  Formal proof  that accessory cells which regulate B-cell clonal prolifer- 
ation are intact in these B-cell defective mice was obtained by using thioglycol- 
late-activated peritoneal macrophages from them to potentiate normal CBA/ 
Cum spleen or lymph node B cells. As shown in Table VIII, all strains of mice 
were  equivalent in  the  ability of their macrophages to  elaborate  diffusible 
enhancing factors. 
Discussion 
The studies presented here provide evidence that functional B cells capable of 
clonal proliferation in soft agar culture are completely lacking in CBA/N mice 
and confirm that this is an intrinsic B-cell defect.  Manipulation of the culture 
conditions,  such  that  colony  number  is  a  linear  function  of the  number  of 
functional B cells present, did not facilitate colony formation by up to l0  s CBA/N PAUL  W.  KINCADE 
TABLE  VII 
Responses of C3H Mice to B-Cell Mitogens in Liquid Culture 
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Experiment I  Experiment II 




Medium  693  1,241  382  444 
AM  7,387 (10.7)  21,208 (17.1)  8,925 (23)  10,379 (23) 
LPS  2,015 (2.9)  2,261  (1.8)  596 (2)  696 (2) 
DS  2,331 (3.4)  10,842  (8.7)  4,771 (12)  6,903 (16) 
Medium  1,055  858  945  1,617 
AM  4,961 (4.7)  9,340 (10.9)  14,686 (16)  14,305  (9) 
LPS  8,004 (7.6)  14,185  (16.5)  13,736 (15)  12,219 (8) 
DS  2,702 (2.6)  8,553 (10.0)  8,847 (9)  15,728  (10) 
Medium  1,151  884 
AM  3,148 (2.7)  4,951 (5.6) 
LPS  5,485 (4.8)  11,620 (13.1) 
DS  5,207 (4.5)  10,789  (12.2) 
Data  represent the  mean  '25IUdR uptake  (cpm)  of triplicate cultures  (stimulation over back- 
ground) prepared in 5% fetal calf serum or serum-free medium. 
TABLE  VIII 
Ability of Macrophages from Different Strains of Mice to Enhance  B- 
Lymphocyte  Colony Formation 
Colonies/cul- 
Cells  cultured  Potentiated by:  ture ± SD 
CBA/Cum  spleen (104)  PBS  28 ± 6 
LPS  99 ± 11 
CBA/Cum  M~b  120 _+ 12 
CBA/N M~  112  ±  13 
C3HeB/FeJ M&  127  ±  38 
C3H/HeJ M~b  103  ±  26 
B6D2F,/Cum Mcb  98 ±  25 
CBA/Cum lymph node (5  x  104)  PBS  86 ±  9 
LPS  263  __ 27 
CBA/Cum M~b  276  ±  27 
CBA/N Mob  267  ±  22 
C3HeB/FeJ M&  277  ±  35 
C3H/HeJ M~b  304 ±  51 
B6D2F,/Cum M~b  287  +_ 41 
Thioglycolate-activated  peritoneal  macrophages  (M&)  were  allowed  to  adhere  to 
culture dishes, washed, and covered by a spacer gel as described in the Materials and 
Methods.  Cultures  of spleen  or  lymph  node  cells  were  prepared  over  these  and 
resulting colonies were scored 5 days later. 
cells in single culture dishes. Numbers and function of bone marrow CFU-c and 
CFU-s, functional peritoneal macrophages, and levels of serum inhibitors were 
all normal in CBA/N mice. As in previous studies (8), cell mixing experiments 
negated the possibility that active suppressor mechanisms could be responsible 
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Some proliferative responsiveness to agar-derived mitogens was suggested by 
3-day liquid cultures of CBA/N cells and LPS responses in such cultures were 
oi~n surprisingly large.  Nonspecific B-cell activation has been achieved with 
liquid cultures of CBA/N B cells with high concentrations of LPS (8) and serum 
IgM levels of CBA/N mice are elevated after LPS injection (11). CBA/N B cells 
differentiated to plasma cells containing large amounts of immunoglobulin in 
cultures prepared at high initial cell density with LPS. The same cells prolifer- 
ated and differentiated poorly compared to normal B cells, however, when the 
number of cells per culture was decreased eightfold. These findings suggest that 
defective mice may have  B  cells that  are intrinsically unable to  divide and 
mature in dilute in vitro culture or form colonies in semisolid culture where cell 
contact is minimized. The cell density in the low-density liquid cultures was 
approximately  1.8  x  103/mm  2  after  settling  to  the  bottom  of the  dishes  as 
compared to a maximum of 1 x  103/ram 3 in the gel cultures. Alternatively, these 
particular culture conditions may select for a  subpopulation of B  cells which 
CBA/N mice lack.  Cell density has been reported by others to have profound 
effects on  the  efficiency of in  vitro  B-cell  differentiation and  the  classes  of 
immunoglobulin which are expressed (19, 21). 
CBA/N mice possess B cells which are capable of responding to antigens via 
participation of T  cells,  although the magnitude of these responses are often 
slightly subnormal (8, 9),  and the quality of the antibody produced may differ 
from that produced by normal animals (24). The most striking abnormality of 
these  mice  is  their  inability  to  respond  to  those  antigens  that  elicit  B-cell 
responses in the absence of functional T cells. The total failure of CBA/N B cells 
to form in vitro colonies suggests that the assay preferentially, and perhaps 
exclusively, detects a subpopulation of B cells whose function is not dependent 
on T cells. 
Several investigators have suggested the existence of a  discrete functional 
category of thymus-independent B  cells  (termed B1)  which might precede in 
ontogeny and/or phylogeny, a distinct thymus-dependent B-cell population (B2) 
(25, 26). The reverse association, namely, that B2 cells might be an immature 
form orB1, has also been suggested (27, 28), and CBA/N mice are said to have an 
immature distribution  of B  cells with respect to cell-surface immunoglobulin 
(13).  A  possibility  that  is  still  open  is  that  these  two  categories of B  cells 
represent completely separate  avenues of differentiation,  each one of which 
contain cells of different maturational stages. 
Evidence has been presented that in certain conditions of antigen priming, B1 
cells have an apparent size difference from B2 cells (29), and that responses to 
most,  if not  all,  thymus-independent antigens  are mediated by complement 
receptor-negative (CR-)  B  cells without participation  of complement compo- 
nents  (30-35).  The  most  immature Ig  + B  cells  lack CR;  some of these  may 
eventually become Ig  ÷, CR  ÷, and this maturation is reported to be genetically 
controlled  (36-38).  The  incidence  of CR  ÷  lymphoid cells  in  adult  tissues  is 
variable (39), but Ig  ÷, CR- lymphocytes usually comprise 30-60%  of splenic B 
cells  (34,  38). Interestingly, cells taken from in  vitro  colonies at  the end of 
culture have been found to lack CR (40). Improvements in methodology have 
increased the efficiency of B-cell cloning, but still  only a  minority of B  cells 
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(10).  Further  analysis of the CR status of clonable B  cells at the initiation  of 
culture,  and  the  possible  role  of activated  complement  in  colony  formation 
should test the relatedness of these findings. That is, the cells that are missing 
in CBA/N lymphoid tissues and that form colonies in vitro might be Ig  +, CR- B1 
type lymphocytes. 
A number of observations suggest that although B1 cells and colony-forming 
cells may be distinct from B2 cells, neither is homogeneous. It has been shown 
that B1 cells include virgin and antigen-experienced cells of different sizes (29, 
41).  Differential responsiveness of various populations of B cells to different T- 
independent mitogens/polyclonal activators with production of different classes 
of Ig  is  well-known  (references  42-44;  P.  W.  Kincade  and  J.  F.  Kearney, 
unpublished observations). Most colony-forming B cells are probably IgM  + and 
Ia  ÷, but since we have only examined cells from mature lymphoid organs under 
unpotentiated conditions, the existence of a minority of functional cells lacking 
one or both of these surface receptors is possible (3).  B cells capable of colony 
formation are present among the earliest functional  B  cells in fetal liver and 
have been found in every lymphoid tissue of adult animals with the exception of 
the thymus (1, 45).  Preliminary experiments with a  rabbit antiserum to puta- 
tive  mouse  8  (46)  indicate  that  2/s-s/4  of colony-forming  B  cells  are  8 + and 
hypersensitive to the antiserum,  whereas the remainder is refractory to treat- 
ment with it  (P.  W.  Kincade  and R.  M.  E.  Parkhouse,  unpublished  observa- 
tions). All of these observations are consistent with the notion that B1 and B2 
are separate categories of cells which may both include diverse subcategories of 
cells. The possible lineal relationship of the two, as well as the origin,  average 
lifespan,  and  migration  patterns  of B1 cells,  can be investigated by injecting 
various populations of normal  cells into  CBA/N mice and following their fate 
with the in vitro cloning technique. 
Liquid and semisolid culture responses of C3H/HeJ B cells form an interesting 
contrast  to those  of CBA/N mice.  C3H/HeJ mice taken  from  an  appropriate 
breeding  colony have  approximately  10%  as  many  colony-forming B  cells  as 
other histocompatible C3H substrains.  Previously, the only known deficit asso- 
ciated with these mice was in reactivity to certain forms of endotoxin (LPS) (14- 
18). Paradoxically, they mounted excellent liquid culture proliferative responses 
with  agar-derived  mitogens  which  are  important  for  colony  formation.  The 
results are, therefore, subject to several different interpretations.  A trivial one 
is that LPS is a vital factor in colony formation.  The most likely source of LPS 
contamination is the agar used to support colonies since the mitogens native to 
our fetal calf serum differ from LPS in requiring 2 ME for B-cell activation (P. 
W. Kincade, unpublished observations). The importance of contaminating  LPS 
in colony formation can be tested by adding anti-LPS antibodies to the cultures, 
since free antigen-antibody complexes are not inhibitory (3). A second possibil- 
ity is that 3-day liquid culture responses do not adequately assess the ability of B 
cells to undergo the prolonged division at infinitely low-cell density necessary 
for  colony  formation.  These  possibilities  are  under  investigation.  It  is  also 
tenable  that  C3H/HeJ  mice  have  a  quantitative  deficit  in  B1.  It  has  been 
reported  that  they  are  capable  of in  vitro  and  in  vivo responses to  thymus- 
independent  antigens  other than LPS (15-17), but it is necessary to test their 
functional capability in a  system where responding cells are limiting  (41). The 260  CBA/N  AND  C3H]HEJ  B  LYMPHOCYTES 
incidence of cells with various B  markers and density of B-cell surface Ig are 
reportedly normal in C3H/HeJ mice (16, 47). 
From numerous parallel studies of the requirements for liquid culture respon- 
siveness and colony formation (P. W. Kincade, unpublished observations), it is 
apparent  that  proliferative  ability is a  necessary,  but not sufficient,  require- 
ment for colony formation.  The  latter  process is  much  more  complex and  is 
dependent on 2 ME,  macrophage-derived  factors,  and substances in fetal calf 
serum in addition to an appropriate stimulating mitogen. The selectivity of the 
technique,  which  is  demonstrated  by these  studies,  suggests  that  it  will  be 
invaluable in defining functional B-cell subpopulations, their requirements for 
activation and differentiation,  and their status in immune-deficiency diseases. 
Summary 
B  cells from  CBA/N mice did not form colonies in  semisolid agar  cultures 
under  circumstances  where  normal  B-cell  clonal  proliferation  is  linear  with 
respect  to  the  number  of functional  cells  cultured.  This  was  not  due  to  the 
unresponsiveness  of CBAJN  cells  to  mitogens,  and  under  appropriate  liquid 
culture  conditions  many  CBA/N  lymphocytes  differentiated  to  plasma  cells 
containing  large amounts of IgM in response to LPS.  On the other hand,  the 
same cells proliferated and matured poorly in liquid cultures prepared at low- 
cell density. The frequency of granulocyte-macrophage progenitors and multipo- 
tential  hemopoietic  stem  cells  in  bone  marrow,  ability  of peritoneal  macro- 
phages to elaborate  soluble enhancing  factors,  and levels of serum inhibitors 
were normal  in CBA/N mice. Together with the results of cell-mixing experi- 
ments, these findings confirm the selective and intrinsic  nature of the CBA/N 
deficiency. It is suggested that the B-cell-cloning technique may be of value in 
selectively enumerating  and  assessing  functional  capability  of thymus-inde- 
pendent B cells.  C3H/HeJ mice which have previously only been known to be 
hyporesponsive to  certain  forms  of lipopolysaccharide  had  a  subnormal  inci- 
dence of colony-forming B cells. 
The author is indebted to Ms. Grace Lee and Ms. Kathleen Murtaugh for their encouragement as 
well as for their dedicated and expert technical assistance. 
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